Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 13, 2003

View Archived Issues

Sunesis and Biogen to discover therapeutics for inflammatory and autoimmune diseases

Type 2 diabetic patients complete first six-month treatment course with Metformin GR

EntreMed licenses thalidomide analogues to Celgene

NDA for Ganite reactivated

Triangle files MAA for emtricitabine

Allos Therapeutics further expands oncology development pipeline

Abbott claims P2X antagonists for pain and urinary incontinence

New inhibitors of IL-12 and/or IL-4 signaling identified at Cell Therapeutics

Merck Frosst develops novel PDE4 inhibitors

Aminoalcohol beta3-adrenoceptor agonists and their use claimed by Fujisawa

Altana researchers investigate novel anti-H. pylori agents

New TGF-beta antagonists for cancer and other uses covered by Lilly patent

Protein kinase inhibitors discovered by Schering scientists

Japanese approval sought for Kissei's mitiglinide

Peginterferon alfa-2a submitted for approval as hepatitis therapy in Japan

Phase II study of RTX in interstitial cystitis commences

Iressa review by the FDA will take more time than anticipated

Merck intends to obtain full ownership of Banyu

ZymoGenetics and Novo Nordisk join forces to develop IL-21

New-generation TTS product cleared for human testing

Promising effects of AEOL-10113 in hyperoxic preterm fetal baboons

Ariad files IND for AP-23573

Infliximab granted priority review by the FDA for fistulizing CD

Moli-1901 granted orphan drug status in Europe

Yamanouchi submits NDA for YM-905 to treat overactive bladder

Muscarinic receptor antagonist with better selectivity for bladder over salivation than tolterodine

Prasterone to be reviewed by EMEA

Advisory committee recommends FDA approval of telithromycin for RTI

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...